Mycopathologia

, Volume 134, Issue 2, pp 75–82 | Cite as

Candida biotypes in patients with oral leukoplakia and lichen planus

Candida bio types in leukoplakia and lichen planus
  • Verónica Lipperheide
  • Guillermo Quindós
  • Yolanda Jiménez
  • José Pontón
  • José Vicente Bagán-Sebastián
  • José Manuel Aguirre
Human and Animal Mycology

Abstract

Prevalence of yeasts in 35 leukoplakia and 34 oral lichen planus patients was compared with that observed in persons without oral diseases. Serotype and morphotype were determined on Candida albicans isolates. Yeasts were isolated from the oral cavity specimens of 43.7% of the patients. C. albicans (serotype A) was the predominant species (76% in leukoplakia, 88.2% in lichen planus and 60.8% in healthy persons). Sixteen morphotypes were encountered on malt extract agar, being 732, 733, 734, 753 and 754 the most frequently found. Morphotypes SP1N and SP1Y were the most common on Sabouraud-trypheniltetrazolium agar (68.4% of the isolates from leukoplakia and 73.3% from lichen planus, but only 46.6% of the isolates from healthy oral mucosa showed SP1N morphotype). Presence of oral lesions was associated with a marked reduction in the yeast species and C. albicans biotypes, suggesting that C. albicans and particularly some of its biotypes, show a high potential of adaptation to the changes associated with the development of oral leukoplakia and lichen planus.

Key words

Candida leukoplakia lichen planus biotypes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Contreras I, Pontón J, Quindós G. Prevalence of Candida parapsilosis in the oral cavities of infants in Spain. Clin Infect Dis 1994; 18: 480–481.PubMedGoogle Scholar
  2. 2.
    Odds FC. Candida and Candidosis, 2nd ed. London: Baillière Tindall, 1988: 117–123.Google Scholar
  3. 3.
    Krogh P. The role of yeasts in oral cancer by means of endogenous nitrosation. Acta Odontol Scand 1990; 48: 85–88.CrossRefPubMedGoogle Scholar
  4. 4.
    Jepsen A, Winther JE. Mycotic infection in oral leukoplakia. Acta Odontol Scand 1965; 25: 239–256.CrossRefGoogle Scholar
  5. 5.
    Krogh P, Holmstrup P, Thorn JJ, Vedtofte P, Pindborg JJ. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 1987; 63: 48–54.CrossRefPubMedGoogle Scholar
  6. 6.
    Cawson RA, Lehner T. Chronic hyperplastic candidiasiscandidal leukoplakia. Br J Dermatol 1968; 89: 497–503.CrossRefGoogle Scholar
  7. 7.
    Field EA, Field JK, Martin MV. Does Candida have a role in oral epithelial neoplasia? J Med Vet Mycol 1989; 27: 277–294.CrossRefPubMedGoogle Scholar
  8. 8.
    Lundström IMC, Anneroth GB, Holmberg K. Candida in patients with oral lichen planus. Int J Oral Surg 1984; 13: 226–238.CrossRefPubMedGoogle Scholar
  9. 9.
    Phongpaichit S, Mackenzie DWR, Fraser C. Strain differentiation of Candida albicans by morphotyping. Epidem Infect 1987; 99: 421–28.CrossRefGoogle Scholar
  10. 10.
    Hunter P, Fraser CMA, Mackenzie DWR. Morphotype markers of virulence in human Candidal infection. J Med Microbiol 1989; 28: 85–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Quindós G, Fernández-Rodriguez M, Burgos A, Tellaetxe M, Cistema R, Pontón J. Colony morphotype on Sabouraud-Triphenyl tetrazolium agar as a simple and unexpensive method for Candida subspecies discrimination. J Clin Microbiol 1992; 30: 2748–2752.PubMedGoogle Scholar
  12. 12.
    Oliver AJ, Reade PC. Morphotypes of oral isolates of Candida albicans from patients infected with the human immunodeficiency virus. J Med Vet Mycol 1993; 31; 289–297.CrossRefGoogle Scholar
  13. 13.
    Borromeo GL, McCullough MJ, Reade PC. Quantitation and morphotyping of Candida albicans from healthy mouths affected by etythematous candidosis. J Med Vet Mycol 1992; 30: 477–480.CrossRefPubMedGoogle Scholar
  14. 14.
    Martin MV, Lamb DJ. Frequency of Candida albicans serotypes in patients with denture-induced stomatitis and normal denture wearers. J Clin Pathol 1982; 35: 888–891.CrossRefPubMedGoogle Scholar
  15. 15.
    Hasenclever HF, Mitchell WO. Antigenic studies of Candida. I. Observations of two groups in Candida albicans. J Bacteriol 1961; 82: 570–573.PubMedGoogle Scholar
  16. 16.
    Hasenclever HI, Mitchell WO. Antigenic studies of Candida. III. Comparative pathogenicity of Candida albicans group A, group B and Candida stellatoidea. J Bacteriol 1961; 82: 578–581.PubMedGoogle Scholar
  17. 17.
    Brawner DL, Cutler JE. Oral Candida albicans isolates from non-hospitalized normal carriers, immunocompetent hospitalized patients and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol 1989; 27: 1335–1341.PubMedGoogle Scholar
  18. 18.
    Auger P, Dumas C, Joly J. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine. J Infect Dis 1979; 135; 590–594.Google Scholar
  19. 19.
    Burgos A, Bikandi J, Fernández-Rodriguez M, Pontón J, Cistema R, Quindós G. Correlación entre los serotipos A y B de Candida albicans y su sensibilidad a anfotericina B y 5-fluorocitosina. Rev Esp Quimioter 1992; 5: 79–85.Google Scholar
  20. 20.
    McCullough MJ, Ross BC, Dwyer BD, Reade PC. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology 1994; 140: 1195–1202.CrossRefPubMedGoogle Scholar
  21. 21.
    Burford-Mason AP, Weber JCP, Willoughby JMT. Oral carriage of Candida albicans, ABO group and secretory status in healthy subjects. J Med Vet Mycol 1988; 26: 49–56.CrossRefPubMedGoogle Scholar
  22. 22.
    McGinnis M. Laboratory Handbook of Medical Mycology. New York: Academic Press, 1980: 411–430.Google Scholar
  23. 23.
    Mackenzie DWR. Serum tube identification of Candida albicans. J Clin Pathol 1962; 15: 65–67.CrossRefGoogle Scholar
  24. 24.
    Aguirre JM, Lipperheide V, Ribacoba L et al. Prevalence of Candida among HIV-infected Spanish patients. Second International Workshop on the Oral Manifestations of HIV Infection. Menlo Park, USA, 1993.Google Scholar
  25. 25.
    Tellaetxe Isusi M. Caracterización subespecifica de los aislamientos orales de Candida y su relación con el desarrollo de la estomatitis protética. Thesis. Bilbao, Spain: Faculty of Medicine and Odontology, Basque Country University, 1993.Google Scholar
  26. 26.
    Arendorf TM, Walker DM, Kingdom RJ, Roll JRS, Newcombe RG. Tobacco smoking and denture wearing in oral Candida leukiplakia. Br Dent J 1983; 155: 340–343.CrossRefPubMedGoogle Scholar
  27. 27.
    Budtz-Jørgensen E, Holmstrup P, Krogb P. Fluconazole in the treatment of Candida-associated denture stomatitis. Antimicrobial Agents Chemother 1988; 32: 1859–1863.Google Scholar
  28. 28.
    Walker DM, Arendorf TM. Candidal leukoplakia, chronic multifocal candidosis and median rhomboid glossitis. In: Samaranayake LP Macfarlane TW (eds), Oral Candidosis. London: Wright, 1990: 184–199.Google Scholar
  29. 29.
    Gioanni J, Mazeau C, Farges MF, Viot M, Zanghellini E, Schneider M. Sécrétion par Candida albicans de substances stimulant Ia prolifération d'une lignée cellulaire d'épithelioma malpighien de Ia cavité buccale. Bul Cancer 1991; 78: 469–471.Google Scholar
  30. 30.
    Reed MF, Scragg RM, Williams DM, Soames JV. In vivo effects of Candida albicans products on rat oral epithelium. J Oral Pathol Med 1990; 19: 326–329.CrossRefPubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Verónica Lipperheide
    • 1
  • Guillermo Quindós
    • 1
  • Yolanda Jiménez
    • 2
  • José Pontón
    • 1
  • José Vicente Bagán-Sebastián
    • 2
  • José Manuel Aguirre
    • 3
  1. 1.Departamento de Inmunología, Microbiología y Parasitologia, Facultad de Medicina y OdontologiaUniversidad del País Vasco (UPV-EHU)BilbaoSpain
  2. 2.Departamento de Medicina Bucal, Facultad de Medicina y OdontologiaUniversidad de ValenciaValenciaSpain
  3. 3.Departamento de Estomatología, Facultad de Medicina y OdontologiaUniversidad del País VascoBilbaoSpain

Personalised recommendations